Vujasinovic, M., Ebrahimi, F., Roelstraete, B., Bergman, D., Sun, J., Sadr‐Azodi, O., Löhr, J. ‐Matthias, & Ludvigsson, J. F. (2025). Metabolic Dysfunction‐Associated Steatotic Liver Disease and Pancreatic Disease—A Population‐Based Nationwide Cohort and Sibling‐Controlled Study. United European Gastroenterology Journal. Portico. https://doi.org/10.1002/ueg2.12761

Yap, E., Askanase, A., Kalunian, K., Dall’era, M., Hodge, L., Truman, M., & Solomons, N. (2024). #468 Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.136

Petta, S., Targher, G., Romeo, S., Pajvani, U. B., Zheng, M., Aghemo, A., & Valenti, L. V. C. (2024). The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver International, 44(7), 1526–1536. Portico. https://doi.org/10.1111/liv.15930

Bellamy, C. O. C., O’Leary, J. G., Adeyi, O., Baddour, N., Batal, I., Bucuvalas, J., Del Bello, A., El Hag, M., El-Monayeri, M., Farris, A. B., Feng, S., Fiel, M. I., Fischer, S. E., Fung, J., Grzyb, K., Guimei, M., Haga, H., Hart, J., Jackson, A. M., … Demetris, A. J. (2024). Banff 2022 Liver Group Meeting report: Monitoring long-term allograft health. American Journal of Transplantation, 24(6), 905–917. https://doi.org/10.1016/j.ajt.2024.03.008

Dall’Era, M., Kalunian, K., Askanase, A., Solomons, N., Truman, M., Hodge, L., & Yap, E. (2024). P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS. Poster Presentations, A104.2-A105. https://doi.org/10.1136/lupus-2024-el.141

Thompson, R. J., Artan, R., Baumann, U., Calvo, P. L., Czubkowski, P., Dalgic, B., D’Antiga, L., Di Giorgio, A., Durmaz, Ö., Gonzalès, E., Grammatikopoulos, T., Gupte, G., Hardikar, W., Houwen, R. H. J., Kamath, B. M., Karpen, S. J., Lacaille, F., Lachaux, A., Lainka, E., … Kjems, L. (2023). Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. JHEP Reports, 5(8), 100782. https://doi.org/10.1016/j.jhepr.2023.100782

Sharma, R., Simon, T. G., Stephansson, O., Verna, E. C., Emond, J., Söderling, J., Roelstraete, B., Hagström, H., & Ludvigsson, J. F. (2023). Pregnancy Outcomes in Women With Autoimmune Hepatitis – A Nationwide Population-based Cohort Study With Histopathology. Clinical Gastroenterology and Hepatology, 21(1), 103-114.e10. https://doi.org/10.1016/j.cgh.2021.12.024

Wang, X. (2022). Challenges and opportunities in nonalcoholic steatohepatitis. Medical Review, 2(4), 328–330. https://doi.org/10.1515/mr-2022-0024